GlassScriptPhysician profile
Timothy D Chilton
NPI 1891255774
$10,104.34
in general payments reported to CMS, 2019-2025
27 companies · $5,539 in 2025
The $5,539 reported for 2025 was more than what 85% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $59.68 · 2023: $221 · 2024: $4,035 · 2025: $5,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,198 · Travel and Lodging: $3,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,198.21 |
| Travel and Lodging | $3,597.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,933.69 | 2021-2025 | Endurant Iis, Valiant Captivia, Pivox Oblique Lateral Spinal System |
| Alphatec Spine, INC | $1,216.16 | 2025 | Other - Miscellaneous |
| Cook Medical LLC | $1,152.68 | 2024-2025 | Zilver Ptx, Zenith Spiral-Z, Zenith |
| Penumbra, INC. | $725.78 | 2024-2025 | Indigo System, Penumbra System |
| Abbott Laboratories | $479.21 | 2023-2025 | Esprit, Hi-Torque Command, Diamondback Peripheral |
| Lemaitre Vascular, INC. | $433.42 | 2024-2025 | Restoreflow, Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Endologix LLC | $323.96 | 2024 | Torus Stent Graft System, Endocross Device |
| Kerecis Limited | $279.81 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Silk Road Medical, INC. | $224.77 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Stryker Corporation | $172.89 | 2025 | Artix Mt |
| W. L. Gore & Associates, INC. | $152.79 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, C3 Delivery System |
| Sanara Medtech INC. | $143.28 | 2024 | Celleraterx |
| Cordis US Corp. | $122.51 | 2024 | Angioguard |
| Boston Scientific Corporation | $97.95 | 2024 | Eluvia, Ranger |
| Philips North America LLC | $88.90 | 2024 | (Az7) Lasers |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $86.86 | 2024 | Entre Plus, Flexitouch Plus |
| Angiodynamics, INC. | $85.27 | 2022-2023 | Angiovac |
| Smith+Nephew, INC. | $76.72 | 2024-2025 | Grafix Pl, Versajet |
| Abiomed | $72.80 | 2024 | Impella |
| Mimedx Group, INC. | $51.24 | 2024-2025 | |
| Ossur Americas, INC. | $46.94 | 2025 | |
| Baylis Medical Technologies INC. | $31.45 | 2024 | |
| Aroa Biosurgery Incorporated | $24.98 | 2025 | |
| Janssen Pharmaceuticals, INC | $23.18 | 2024 | Xarelto |
| Reprise Biomedical, INC. | $22.30 | 2025 | Miro3d |
| Solventum Corporation | $19.07 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Becton, Dickinson and Company | $15.73 | 2024 | Covera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Chilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.